DSIJ Mindshare

Sensex, Nifty close in red; Future Retail locks in at lower circuit, Future Lifestyle Fashions declines by nearly 5 per cent

Geyatee Deshpande 0 2846 Article rating: 3.9

Domestic benchmark indices closed flat on Friday as Sensex dropped by 0.03 per cent or 11.57 points to settle at 38,128.90 while Nifty fell by 0.19 per cent or 21.30 points to end at 11,194.15.

Lupin gets USFDA tentative approval for type 2 diabetes tablets

Anthony Fernandes 0 1556 Article rating: 5.0

Pharma-major, Lupin Limited, announced that it has received tentative approval for its Empagliflozin and Linagliptin tablet in the strengths of 10 mg/5 mg and 25 mg/5 mg from United States Food and Drug Administration (USFDA), to commercialise a generic version of Glyxambi tablets, of Boehringer Ingelheim Pharmaceuticals, Inc.

RSS
First36343635363636373639364136423643Last
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR